Stock Events

Pharmaron Beijing 

€1.79
+€0.03+1.7% Today

Statistics

Day High
1.79
Day Low
1.79
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
-
P/E Ratio
8.92
Dividend Yield
1.49%
Dividend
0.03

Upcoming

Dividends

1.49%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
1.03%
1Y Growth
5.32%

Earnings

29OctExpected
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Q3 2024
0
0.23
0.46
0.69
Expected EPS
0.250946128344548
Actual EPS
0.1930806195136

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 17Q1.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vitro biology, DMPK, in vivo pharmacology, and compound management services; chemistry, manufacturing, and controls services. It also provides clinical development services, including integrated radio labelled science, clinical development, and clinical trial recruitment services; safety assessment, integrated drug discovery, and bioanalysis services; and biologics and cell and gene therapy services, comprising biologics laboratory, biologics CDMO, cell and gene therapy laboratory, and gene therapy CDMO services. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Show more...
CEO
Dr. Boliang Lou Ph.D.
Employees
20342
Country
CN
ISIN
CNE100003PG4
WKN
000A2PV00

Listings